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Abstract
Objective: Adherence is a problem in the topical treatment of acne. This study was designed to
evaluate the efficiency of current topical treatment and adherence in patients.
Methods: Patients with acne vulgaris who had recently been prescribed a topical therapy were
selected. A dermatologist-directed questionnaire was completed. Demographic data, acne sever-
ity, treatment and the manner of use, side effects, and reason for discontinuation were recorded.
Results: A total 250 patients were included, 178 female (71.2%) and 72 male (28.8%) partic-
ipants, mean age was 18.6 2.8 years. Of 250 patients, 114 (45.6%) had given up therapy for two
reasons: unresponsiveness in 71 (62.3%) and side effects in 43 (37.7%) patients. For antibacterial
treatments, the rate of unresponsiveness was higher but the rate of side effects was lower.
Discontinuation owing to unresponsiveness was higher in patients with severe acne. Side effects
were higher in patients with comedonal-type acne. The lowest rates of side effects and discon-
tinuation were among every-other-night users.
Conclusion: In this study, patients with acne gave up treatment owing to side effects and
unresponsiveness, which reduced the treatment efficiency.
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Introduction
Approximately 80% of young adults and
adolescents have acne vulgaris, a chronic
inflammatory disease of the skin. Acne vul-
garis is characterized by open and closed
comedones and lesions with inflammatory
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nodules, pustules, and papules, which typi-
cally affect the face, chest, and back.1,2
Acne vulgaris is a chronic disease that
requires prolonged therapy for a satisfacto-
ry outcome. Treatment adherence in
patients is a major problem, particularly
for topical treatments, owing to side effects
and the prolonged treatment time.
Insufficient adherence leads to recurrence
of acne, patient dissatisfaction, and
increased medical costs. Numerous studies
have reported low adherence rates for acne
treatments, with the United States having
the lowest rate of 11.74%.3
This study evaluated the choices in top-
ical treatment for acne vulgaris and patient
adherence to the prescribed treatment.
Patients and methods
This study included patients with acne vul-
garis who were prescribed a topical therapy
in the previous 6 months at outpatient clin-
ics of Sakarya University Faculty of
Medicine Training and Research Hospital,
Department of Dermatology in Turkey.
After verbally consenting to the study, the
status of patients was evaluated; no further
examination or investigation was done.
Participants completed a dermatologist-
directed questionnaire based on a mini
questionnaire for topical therapies devel-
oped by Pawin et al.4 The details presented
were anonymized such that the identity of
the patients cannot be ascertained. In this
study, demographic data were collected for
each participant, including the Fitzpatrick
skin type, the duration and severity of
acne, the most recently prescribed treat-
ment, the manner in which the patient
used the treatment, side effects or problems
with the treatment, the reason for therapy
discontinuation (if applicable), peeling
applications, makeup use, and daily sun
exposure. Approval was received from the
Sakarya University Faculty of Medicine
Ethics Committee for this study.
Statistical analyses
IBM SPSS ver. 24.0 (IBM Corp., Armonk,
NY, USA) was used for the statistical anal-
yses. The Mann–Whitney U test was used
for comparisons of abnormally distributed
data; the Kolmogorov–Smirnov test was
applied for convenience in parameters
with normal distribution before comparing
continuous variables. The independent
t-test was used to compare the descriptive
statistics and quantitative data, and the chi-
square test was used for the comparison of
qualitative data.
Results
This study included 250 patients: 178
females (71.2%) and 72 males (28.8%)
with a mean age 18.6 2.8 years. The sever-
ity of acne was recorded at the first visit,
according to the Global Acne Grading
System; 104 (41.6%) patients had mild
acne, 137 (54.8%) had moderate acne, and
9 (3.6%) patients had severe acne. No differ-
ences were noted in terms of the severity of
acne among the treatment groups. Of the
250 patients, 114 (45.6%) discontinued ther-
apy before the scheduled time, indicating an
adherence rate of 54.4%. The reasons for
discontinuation reported by patients includ-
ed unresponsiveness (71/114; 62.3%) and
side effects (43/114; 37.7%) such as irrita-
tion, erythema, scaling, itching, and sting-
ing. We detected no differences in terms of
discontinuation among the treatment
groups. Side effects were reported by
83/250 (33.2%) patients. The rate of anti-
bacterial use was highest in the unresponsive
group (p¼ 0.004). The rate of side effects
was significantly lower in patients using
antibacterial treatments than in those
using other drugs (p¼ 0.002). The discon-
tinuation rate owing to unresponsiveness
was highest in patients with severe acne
(p¼ 0.048). The rate of side effects was
significantly higher in patients with
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comedone-dominant acne (p¼ 0.030).
Retinoid-containing topical drugs were pre-
scribed more often for patients with
comedone-dominant and mixed acne types
(p< 0.001) (Table 1). Every-other-night
users reported the fewest side effects and
lowest discontinuation rates (p¼ 0.014 and
p< 0.001) (Table 2).
Unresponsiveness was the most common
reason for discontinuation among all patient
types, with the highest significance in patients
with severe acne (p¼ 0.048). Reasons for dis-
continuation were not correlated with the
type of acne, makeup use, sun exposure,
peeling habits, or Fitzpatrick skin type.
Side effects were also not correlated with
peeling habits, sun exposure, makeup use,
severity of acne, or Fitzpatrick skin type.
Patients with comedonal-type acne had a
significantly higher rate of side effects than
those with other acne types (p¼ 0.030).
Patients with comedonal and mixed acne
types were treated most often with
retinoid-containing topical medication,
whereas patients with papulopustular-type
acne were treated more frequently with
antibacterial therapy (p< 0.001).
Treatment choice did not differ by sex.
The most frequently prescribed drugs were
antibacterialþbenzoyl peroxide combina-
tions (40.4% in females and 41.7% in
males), followed by topical retinoids in
females (33.7%), and antibacterial treat-
ments in males (26.4%). Rates for discon-
tinuation of therapy did not differ by sex
(43.8% in females and 50% in males).
Furthermore, the reasons for discontinua-
tion did not differ by sex: discontinuation
owing to side effects was reported by 38.5%
of females and 36.1% of males, and unre-
sponsiveness was reported by 61.5% of
females and 63.9% of males.
Discussion
Most studies on the topical treatment of
acne have focused on adherence to therapy,
the reasons for adherence, and suggested
solutions.3–11 This study revealed that dis-
continuation occurred mostly with the use
of retinoids (40%), benzoyl peroxide com-
binations (44.1%), and retinoid combina-
tions (60%). Furthermore, the reasons for
discontinuation of these treatments were
reported as a result of side effects, with
rates of 50%, 33.3%, and 65.7%, respec-
tively. Tan et al.3 reported similar findings:
patients adhered less when using topical ret-
inoids and oral antibacterial agents.
Patients taking antibacterials (67.5%) and
benzoyl peroxide combinations (60.7%)
had higher discontinuation rates owing to
acne unresponsiveness. Once-a-day or
every-other-night users had lower rates of
side effects, regardless of the therapy used.
Twice-a-day users reported that side effects
led to their discontinuation, whereas those
who applied treatment less frequently (night
time only or every-other-night users) dis-
continued treatment owing to unrespon-
siveness (p¼ 0.001). These findings
indicate that side effects and unresponsive-
ness are the main reasons for discontinua-
tion of topical treatment in patients with
acne. A literature review by Park et al.5
revealed that adherence was higher among
patients with acne taking oral medication
than in those using topical medication.
In an investigation of adherence and fac-
tors associated with adherence in patients
with acne, Dréno et al.6 reported a poor
adherence rate worldwide (50%), with sig-
nificantly worse rates in Europe than in
Asia and the Americas (adherence rates of
58%, 48%, and 43%, respectively;
p< 0.0001). The authors reported that
poor adherence was independently correlat-
ed with young age (greatest correlation in
those aged <15 years, but also in those aged
15–25 years), the occurrence of side effects,
lack of improvement as evaluated by a der-
matologist, previous systemic therapy, lack
of knowledge about acne treatment, consul-
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lack of patient satisfaction with treatment.
They also reported factors with a positive
effect on adherence, including more severe
acne, use of cosmetics (moisturizers, cleans-
ers), use of either topical therapy alone or
isotretinoin, good clinical improvement as
evaluated by a dermatologist, patient satis-
faction with therapy, and knowledge of
acne treatment. Jones-Caballero et al.6
reported that non-adherence in older
patients was owing to side effects whereas
that in younger patients was owing to for-
getfulness. De Lucas et al.8 suggested that
adherence to treatment increases with a
marked reduction in severity and higher
rates (50%) of improvement. Adherence
is highest when the outcome is rapid and
substantial.
Most patients in this study had moderate
acne severity, although several had severe
acne. Unresponsiveness, an important
factor affecting adherence, may be owing
to an inadequate choice of treatment if
only topical medications are considered
for these moderate and severe cases.
Every-other-day users of topical medica-
tions reported the fewest side effects. In
our study, some twice-a-day users discon-
tinued treatment because of side effects
whereas others discontinued because of
unresponsiveness. More favorable out-
comes might arise from choosing the opti-
mal topical treatment by specifically
targeting the acne type and using it in an
optimal manner. We believe that a good
relationship between the patient and derma-
tologist can help to provide a balance, min-
imizing the possibility of side effects and
unresponsiveness. Understanding the neces-
sity for a prolonged course of treatment for
acne by the patient will also help to main-
tain good adherence. Further investigations
regarding whether counseling or adjustment
of the number and type of office visits make
a difference in compliance will most likely
strengthen these suggestions.
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